To determine the value of proliferating cell nuclear antigen (PCNA) staining as a prognostic indicator in soft-tissue malignant fibrous histiocytoma (MFH), we studied 27 patients who underwent resection including an adequately wide margin but without chemotherapy. The survival rate of patients with
Proliferating cell nuclear antigen (PCNA) in high-grade malignant fibrous histiocytoma: Prognostic value in 48 patients
✍ Scribed by Karsten E. Dreinhöfer; Måns Åkerman; Helena Willén; Christina Anderson; Pelle Gustafson; Anders Rydholm
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- French
- Weight
- 500 KB
- Volume
- 59
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
lmmunostaining for proliferating cell nuclear antigen (PCNA), a marker of cell proliferation, is being increasingly used to study the proliferative activity of tumors, and the PCNA labeling index has been correlated with the prognosis of several malignant neoplasms. Formalin-fixed, paraffin-embedded
## Abstract ## Background DNA ploidy, S‐phase fraction (SPF), and proliferating cell nuclear antigen (PCNA) are considered to be significant prognostic factors in non‐Hodgkin lymphomas. However, reports on their prognostic importance in gastric lymphoma patients are relatively lacking. ## Methods